The U.S. Food and Drug Administration (FDA) is facing renewed criticism over the process by which it approves drugs for market. Recent reports indicate many drugs are approved before they are proven safe, and problems with the agency's structure and processes prevent it from fulfilling its mission. Subsequently, Congress has started using its oversight powers to scrutinize the agency, and the clamor for FDA reform is growing louder.

Though federal agencies responded relatively quickly to the recent outbreak of E.Coli in bagged spinach, the case highlights the need to ensure the safety of the nation's food supply and to have adequate tracking systems in place to do so.

Despite the discovery of three cows infected with bovine spongiform encephalopathy (BSE), or mad cow disease, measures to ensure the safety of the food supply and to keep foreign markets open to American beef have been stalled, according to a report from the Center for Science in the Public Interest (CSPI), OMB Watch, and Consumer Federation of America.